Dose delivery characteristics and lung deposition of indacaterol/glycopyrronium/mometasone furoate (IND/GLY/MF) and IND/MF via Breezhaler(R) device: An Alberta Idealised Throat (AIT) evaluation

Conclusion: Both IND/GLY/MF and IND/MF FDC products demonstrated similar lung deposition and highly consistent doses over the wide range of investigated flow rates, despite differences in the composition of the formulations.

http://erj.ersjournals.com/cgi/content/short/60/suppl_66/2074?rss=1

Source: European Respiratory Journal - December 1, 2022 Category: Respiratory Medicine Authors: Jauernig, J., Fiebich, K., Singh, D., Jaumont, X., Mezzi, K., Jaumont, X. Tags: 05.01 - Airway pharmacology and treatment Source Type: research